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Objective: Higuchi's transverse incision is made at a lower position than the Pfannenstiel transverse
incision and is superior in terms of cosmetic outcomes. The purpose of this study was to examine the
safety and efﬁcacy of novel forms of reduced port surgery for ovarian cysts and uterine ﬁbroids applying
Higuchi's transverse incision.
Methods: In 33 patients with ovarian cysts who underwent low-position single-incision laparoscopic
surgery (L-SILS)-modiﬁed single-port laparoscopy placed in the 2e3-cm Higuchi's incision above the
pubis, patient's characteristics and perioperative outcomes were compared with those of patients who
underwent multiport laparoscopy (n¼ 53). In addition, 18 patients with uterine ﬁbroids who underwent
dual-port laparoscopically assisted myomectomy without using power morcellators and conventional
four-port laparoscopically assisted myomectomy were investigated.
Results: There were no signiﬁcant differences between L-SILS and multiport laparoscopy in tumor
diameter, bleeding, hospital stay, or postoperative pain. However, the L-SILS group demonstrated
signiﬁcantly shorter operative and pneumoperitoneum times (p< 0.01 and p< 0.01). In comparison with
cases of uterine ﬁbroids, no signiﬁcant differences were found in maximum ﬁbroid diameter, operative
time, pneumoperitoneum time, or bleeding. However, the dual-port laparoscopically assisted myomec-
tomy group demonstrated a signiﬁcantly shorter length of hospital stay than the conventional lapa-
roscopically assisted myomectomy group (p< 0.05).
Conclusion: We reported novel forms of reduced port surgery applying Higuchi's transverse incision. It
was suggested that these procedures are relatively simple, but ensure the same safety and efﬁcacy as
conventional methods. We intend to increase the number of cases and examine safety, efﬁcacy, and
patient satisfaction for these procedures.
Copyright © 2016, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Compared with laparotomy, laparoscopic surgery results in
fewer perioperative complications, less postoperative pain, shorter
hospitalization, and faster recovery.1 Furthermore, as the evolutions of interest relevant to this
s and Gynecology, The Jikei
ashi, Minato-ku, Tokyo 105-
to).
n for Gynecologic Endoscopy and Mi
.org/licenses/by-nc-nd/4.0/).of energy devices and other medical equipment has led to
improved safety and shorter operative times, reduced port surgery
(RPS) such as single-port laparoscopy and microlaparoscopy have
been developed; these RPS techniques are less invasive and yield
superior cosmetic outcomes compared with conventional surgery,
and multiple studies have reported their utility.2,3
In gynecology, single-port laparoscopy is typically performed
withanumbilical approach, theutilityofwhichhasbeenreportedby
several studies.4e7 However, the surgery is difﬁcult to perform,8,9
and a number of studies have reported postoperative complica-
tions such as umbilical hernias and refractory infections.10e12nimally Invasive Therapy. Published by Elsevier Taiwan LLC. This is an open access article
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Administration issued a warning regarding the safety of power
morcellators typically used in laparoscopy for uterine ﬁbroids, thus
posing problems for the surgical procedure and ﬁbroid removal.13,14
Higuchi's transverse incision is made at a lower position than
the conventional Pfannenstiel transverse incision and is superior in
terms of cosmetic outcomes. We perform Higuchi's transverse
incision as a standard approach in laparotomy for benign tumors
(except for giant tumors) and for cesarean sections.
In the present study, we applied Higuchi's transverse incision in
RPS; here, we discuss new surgical procedures with the objective of
further improving cosmetic outcomes. We report our introduction
of two new operative procedures: low-position single-incision
laparoscopic surgery (L-SILS), which does not involve the umbili-
cus, for ovarian cysts, and dual-port laparoscopically assisted
myomectomy (2P-LAM), which does not use a power morcellator,
for uterine ﬁbroids.Methods
Higuchi's transverse incision
First, we will describe Higuchi's transverse incision.
(1) Skin incision: The incision is made at a low position, 1.5 cm
above the pubis. The wound is covered by the pubic hair and
thus has a superior cosmetic outcome. This incision also
enables easier surgeries on the bladder, cervix, and else-
where in the pelvis.
(2) Blunt dissection of subcutaneous adipose tissue: The exten-
sive use of blunt dissection of subcutaneous adipose tissue
makes it possible to avoid abdominal wall blood vessel
injury.
(3) T incision of the rectus abdominis fascia: After bluntly
extending the rectus abdominis fascia incision from 2e3 cm
cranial to the skin incision line in a transverse direction to the
lateral margin of the rectus abdominis, a longitudinal inci-
sion is made toward the area directly above the pubic sym-
physis. The opening of a T incision in the rectus abdominis
fascia ensures a sufﬁcient visual ﬁeld.
(4) Longitudinal incision of the peritoneum: Treatment of the
peritoneum while conﬁrming the bladder makes it possible
to avoid bladder injury. The skin, fascia, and peritoneumFigure 1. L-SILS applying Higuchi's transverse incision. (A) The skin incision made at the
transverse incision. Three trocars are attached to the EZ access. L-SILS¼ low-position singleincision sites do not coincide, thus making it possible to
prevent an abdominal incisional hernia.L-SILS for ovarian cysts
(1) A platform is placed in the 2e3 cm Higuchi's transverse
incision superior margin on the pubis (Figure 1A).
(2) A Lap Protector and an EZ access (Hakko Medical, Nagano,
Japan) are used with the platform. Three Versaport trocars
(Medtronic, Minneapolis, MN, USA) are attached to the EZ
access (Figure 1B).
(3) A 5-mm ﬂexible videoscope (Olympus, Tokyo, Japan) is used
to observe the tumor site, tumor size, and possible presence
of adhesions following pneumoperitoneum.
(4) Following ﬁne-needle aspiration of ovarian cyst ﬂuid, the
cyst is resected extracorporeally.The 2P-LAM procedure for uterine ﬁbroids
(1) A camera port is inserted through the umbilicus using the
optical method. A 5-mm ﬂexible videoscope (Olympus,
Tokyo, Japan) is used to observe the possible presence of
intra-abdominal adhesions.
(2) A platform is placed in the 3-cmHiguchi's transverse incision
above the pubis.
(3) A Lap Protector and an EZ access (Hakko Medical, Nagano,
Japan) are used with the platform. Two Versaport trocars
(Medtronic, Minneapolis, MN, USA) are attached to the EZ
access (Figure 2A).
(4) The ﬁbroid is enucleated intra-abdominally, and the wound
in the uterus is sutured under direct observation. The
absence of remaining ﬁbroids is conﬁrmed by palpation.
(5) The enucleated ﬁbroid is collected into an isolation bag,
morcellated with a scalpel in the bag under direct observa-
tion, and removed from the abdominal cavity via the Higu-
chi's transverse incision without using power morcellators
(Figure 2B).
Results
We began performing cystectomy by L-SILS for ovarian cysts in
March 2014. A breakdown of cases is shown in Table 1. Initially, thesuperior margin on the pubis. (B) The platform is placed in the 2e3-cm Higuchi's
-incision laparoscopic surgery.
Figure 2. Dual-port LAM applying Higuchi's transverse incision. (A) The 5-mm trocar for the videoscope is inserted through the umbilicus by the optical method. The platform is
placed in the 3-cm Higuchi's transverse incision above the pubis. Two trocars are attached to the EZ access. (B) The enucleated ﬁbroid from the uterus is collected into an isolation
bag, manually morcellated with a scalpel in the bag, and removed from the abdominal cavity via the Higuchi's transverse incision. LAM¼ laparoscopically assisted myomectomy.
Table 1
Characteristics and perioperative outcomes of ovarian cysts.
L-SILS (n¼ 33) TLC (n¼ 53) pa
Age (y) 31 (19e42) 33 (24e44) 0.077
Body mass index 19.8 (15.8e24.1) 19.6 (18.4e24.4) 0.77
Histologic type <0.01
Teratoma 28 (84.8) 17 (32.1)
Endometriotic 3 (9.1) 31 (58.5)
Others 2 (6.1) 5 (9.4)
Tumor site 0.725
Unilateral 23 (69.7) 35 (66.0)
Bilateral 10 (30.3) 18 (34.0)
Anesthesia 0.983
GA 13 (39.4) 21 (39.6)
GAþ TAP/EP 20 (60.6) 32 (60.4)
Tumor size (cm) 9.3 (4.0e21.0) 8.4 (3.4e17.8) 0.264
Surgical time (min) 110.8 (72e167) 140.5 (76e243) <0.01
Aeroperitoneum time (min) 30.1 (7e92) 109.8 (55e219) <0.01
Estimated blood loss (g) 20.6 (0e340) 42.3 (0e450) 0.234
CRP (mg/dL) 1.29 (0.13e3.57) 1.43 (0.14e6.43) 0.604
VAS
Rest 20.7 (0e52) 22.1 (0e88) 0.710
Motion 43.4 (7e83) 48.7 (0e100) 0.245
Postoperative hospital stay (d) 4.1 (3e6) 4.0 (3e6) 0.446
Values are presented as mean (range) or n (%).
CRP¼ C-reactive protein on the next day; GA¼ general anesthesia; L-SILS¼ low-position single-incision laparoscopic surgery; TAP/EP¼ transversus abdominis
plane block/epidural anesthesia; TLC¼ total laparoscopic cystectomy; VAS¼ visual analog scale on the next day.
a Statistical analysis was performed using the Student t test or the chi-square test. A p value< 0.05 was considered statistically signiﬁcant.
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were teratomas. In a comparison with 53 patients who underwent
conventional multiport laparoscopic cystectomy during that same
period, no signiﬁcant differences were observed in tumor diameter,
bleeding, length of hospital stay, or postoperative pain; however,
patients who underwent L-SILS demonstrated signiﬁcantly shorter
operative and pneumoperitoneum times (p< 0.01 and p< 0.01).
Additionally, in order to eliminate bias due to adhesions and tumor
localization, we compared only cases with unilateral ovarian cysts
(Table 2); we thus found that while L-SILS involved signiﬁcantly
larger tumor diameters (p< 0.05), operative and pneumo-
peritoneum times were shorter (p< 0.01 and p< 0.01).
We began performing 2P-LAM in December 2014 and have used
it in seven patients thereafter (Table 3). In comparisonwith cases of
conventional four-port laparoscopically assisted myomectomy
(LAM) performed during the same period, no signiﬁcant differences
were found in maximum ﬁbroid diameter, operative time,pneumoperitoneum time, or bleeding; however, the 2P-LAM group
demonstrated a signiﬁcantly shorter length of hospital stay than
the conventional LAM group (p< 0.05).
In addition, neither of these novel procedures resulted in any
perioperative complications.
Discussion
The Higuchi's transverse incision was proposed by Shigetsugu
Higuchi, the ﬁrst professor of obstetrics and gynecology at the Jikei
University School of Medicine. The incision is comparable with the
conventional Pfannenstiel transverse incision in some characteristic
ways, as indicated in the methods. The main characteristic of the
Higuchi's transverse incision is a T incision of the rectus abdominis
fascia; bluntly extending the incision in a transverse direction pre-
vents injury to the perforating branches of the deep arteries and
veins of the abdominal wall. Next, a longitudinal incision is made
Table 2
Comparison of unilateral ovarian cysts.
L-SILS (n¼ 23) TLC (n¼ 35) pa
Tumor size (cm) 8.38 (4.0e17.4) 6.65 (3.4e13.4) 0.036
Surgical time (min) 103.5 (72e130) 127.2 (76e193) <0.01
Aeroperitoneum time (min) 28.2 (7e84) 90.1 (55e159) <0.01
Estimated blood loss (g) 3.3 (0e30) 26.5 (0e250) 0.086
Values are presented as mean (range).
L-SILS¼ low-position single-incision laparoscopic surgery; TLC¼ total laparoscopic
cystectomy.
a Statistical analysis was performed using the Student t test. A p value< 0.05 was
considered statistically signiﬁcant.
Table 3
Characteristics and perioperative outcomes of uterine ﬁbroids.
2P-LAM (n¼ 7) conventional LAM (n¼ 11) pa
Age (y) 34 (33e40) 38 (31e47) 0.148
Body mass index 19.6 (17.9e22.2) 20.7 (17.0e24.9) 0.215
Number of ﬁbroids 0.801
1 4 (57.1) 5 (45.5)
2 1 (14.3) 3 (27.3)
3 2 (28.6) 3 (27.3)
Tumor size (cm) 7.04 (6.5e8.7) 7.57 (5.8-10.4) 0.604
Surgical time (min) 204.1 (140e260) 194.3 (147e237) 0.579
Aeroperitoneum time (min) 96.7 (46e141) 86.8 (52e167) 0.532
Estimated blood loss (g) 100 (0e280) 227.7 (0e970) 0.274
Hb (g/dL) 10.6 (9.7e11.5) 10.8 (8.8e13.9) 0.710
CRP (mg/dL) 2.26 (0.84e2.98) 3.45 (0.83e9.05) 0.205
Postoperative hospital stay (d) 4.14 (4e5) 5.09 (4e7) 0.023
Values are presented as mean (range) or n (%).
CRP¼ C-reactive protein on the next day; Hb¼ hemoglobin level on the next day; LAM¼ laparoscopically assisted myomectomy; 2P-LAM¼ dual-port laparoscopically
assisted myomectomy.
a Statistical analysis was performed using the Student t test or the chi-square test. A p value of <0.05 was considered statistically signiﬁcant.
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while conﬁrming the bladder makes it possible to prevent bladder
injury and ensures an adequate visual ﬁeld. We usually perform
Higuchi's transverse abdominalwall incision as a standard approach
for laparotomy for benign tumors and cesarean sections.
Recently, in response to the demand for reducing invasiveness
further, the application of RPS has become widespread. Single-port
laparoscopic surgery through the umbilicus, a form of RPS, was
reported in 2005 as a new approach to tubal pregnancy15; there-
after, its use has grown beyond laparoscopic surgery for benign
tumors, and it has also been introduced for malignant tumors and
in robotic surgeries.16,17 Although many studies have reported on
the utility of RPS,18e20 there are also reports that RPS did not
improve the health-related quality of life,21 and reports of the high
degree of difﬁculty of RPS and problems with umbilical
wounds.8e12 L-SILS, which we introduced in the present study, is an
extremely simple method that permits extracorporeal tumor
resection and removal of the tumor content in a short time. Despite
the small number of cases, an investigation of unilateral teratomas
with no adhesions statistically demonstrated that while tumor
diameter is signiﬁcantly larger than in conventional multiport
laparoscopic surgery, operative and pneumoperitoneum times are
signiﬁcantly shorter. In addition, applying the Higuchi's transverse
incision enables a skin incision above the pubis, which causes the
wound to be hidden completely by pubic hair and underwear,
thereby providing excellent cosmetic outcomes.
Examples of laparoscopic uterine ﬁbroid enucleation include
laparoscopic myomectomy (LM) and LAM. Although LAM is inferior
to LM in terms of cosmetic outcomes, it is a technically simple
procedure that enables suturing of the uterine wound and removalof ﬁbroids through a small incision. In addition, LAM enables
conﬁrmation of small, low-position ﬁbroids by palpation and can
also be performed for relatively large ﬁbroids. A study that
compared LM and LAM found that LAM involved signiﬁcantly
shorter operative times and signiﬁcantly smaller uterine in-
cisions.22 In addition, although power morcellators are typically
used to remove enucleated ﬁbroids, they have been implicated in
potentially disseminating occult uterine malignancy in the
abdominal cavity and causing peritoneal metastasis; thus, in 2014,
the United States Food and Drug Administration issued a warning
against the use of power morcellators in laparoscopic surgery for
uterine ﬁbroids.13,23 Therefore, in order to avoid using a power
morcellator, we introduced a method in which the ﬁbroid iscollected into a bag, morcellated in the bag with a scalpel through
the LAM incision, and removed. Furthermore, in order to improve
cosmetic outcomes, we have applied 2P-LAM, in which a small
Higuchi's transverse incision is completely hidden by pubic hair
and underwear, and in which a 5-mm camera port is inserted
through the umbilicus. Moreover, by making a small incision above
the pubis rather than in the umbilicus, a cesarean section can later
be performed through a Higuchi's transverse incision at the same
site, thus avoiding the need for a new abdominal wound. Despite
the small number of cases, our results indicate that compared with
conventional four-port LAM, regardless of the lack of a signiﬁcant
difference in maximum ﬁbroid diameter, 2P-LAM shows no sig-
niﬁcant difference in operative time, bleeding, or perioperative
complications; results in signiﬁcantly shorter length of hospitali-
zation; is equally safe; and is less invasive.Conclusion
In the present study, we reported on L-SILS and 2P-LAM, novel
forms of RPS for ovarian cysts and uterine ﬁbroids that apply
Higuchi's transverse incision. In the current environment, in which
improved cosmetic outcomes and further reduction in invasiveness
are sought in laparoscopic surgery, both these procedures are
relatively simple, but ensure the same safety and efﬁcacy as con-
ventional methods; therefore, they have potential as novel forms of
RPS. Going forward, we intend to increase the number of cases, and
examine the safety and efﬁcacy of, and patient satisfaction with
these procedures.
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